US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

59.36

+1.031.77%

Volume:8.39M

Turnover:501.62M

Market Cap:263.50B

PE:18.90

High:60.17

Open:59.08

Low:58.92

Close:58.33

Loading ...

Overview Company News Filings

Novo Nordisk's Wegovy Sales Growth Stalls in U.S. Amid Competition, Reimbursement Hurdles -- Market Talk

Market Chatter: Novo Nordisk Settles Federal Lawsuit Over Insulin Prices in Minnesota

MT Newswires Live

GLP-1s are driving returns on R&D investments for Big Pharma, report says

This Company Just Overtook Ozempic Maker Novo Nordisk as Europe's Most Valuable -- Barrons.com

Trump Tariff Uncertainty Will Break This Stock Market Calm, Brace for Another Storm. And 5 Other Things to Know Today. -- Barrons.com

GLP-1s boosts pharma R&D projected return on investment: Deloitte

Is Novo Nordisk A/S (NYSE:NVO) The Best Extremely Profitable Stocks to Buy According to Analyst?

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped

Novo Nordisk Expands Wegovy Savings Program

MT Newswires Live

Deutsche Bank Keeps Their Buy Rating on Novo Nordisk (0QIU)

Novo Nordisk expands Wegovy® $499-per-month offering to additional cash-paying patients via the Wegovy® savings offer

Novo Nordisk Signs $2 Billion Deal for Experimental Obesity Drug -- Update

Novo Nordisk to Pay Up to $2 Billion to License Chinese Company's Weight-Loss Drug -- Barrons.com

5 Low-Leverage Stocks to Buy Amid Trump's Tariff Woes

Novo Nordisk to Pay up to $2 Billion for Rights to Developmental Obesity, Diabetes Drug

MT Newswires Live

Novo Nordisk strikes $2 billion deal with a Chinese company making a GLP-1 drug

Germany's SAP Overtakes Wegovy Maker Novo Nordisk as Europe's Most Valuable Company

Novo Nordisk's Ozempic Drug Faces Declining Sales -- Market Talk

The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NVO/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO\",,,,,undefined,":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"Novo-Nordisk A/S","latestPrice":59.36,"timestamp":1745344049267,"preClose":58.33,"halted":0,"volume":8394124,"delay":0,"floatShares":3183551536,"shares":4439052849,"eps":3.141546,"marketStatus":"Trading","change":1.03,"latestTime":"04-22 13:47:33 EDT","open":59.08,"high":60.17,"low":58.92,"amount":501620317.812868,"amplitude":0.02143,"askPrice":59.38,"askSize":237,"bidPrice":59.37,"bidSize":188,"shortable":3,"etf":0,"ttmEps":3.141546,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":58.33,"dividendRate":0.028265,"preHourTrading":{"tag":"盘前","latestPrice":59.07,"preClose":58.33,"latestTime":"09:29 EDT","volume":1542113,"amount":91442893.54104601,"timestamp":1745328599999},"postHourTrading":{"tag":"盘后","latestPrice":58.7268,"preClose":58.33,"latestTime":"19:59 EDT","volume":76176,"amount":4456781.8966,"timestamp":1745279986865},"volumeRatio":0.96192,"impliedVol":0.5852,"impliedVolPercentile":0.908},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO\",,,,,undefined,":{"symbol":"NVO","floatShares":3183551536,"roa":"22.41%","roe":"80.78%","lyrEps":3.147662,"volumeRatio":0.96192,"shares":4439052849,"dividePrice":1.677784,"high":60.17,"amplitude":0.02143,"preClose":58.33,"low":58.92,"week52Low":57,"pbRate":"12.48","psRate":"6.17","week52High":148.15,"institutionHeld":0.2044,"latestPrice":59.36,"committee":-0.115294,"eps":3.141546,"divideRate":0.028265,"volume":8394124,"delay":0,"ttmEps":3.141546,"open":59.08,"prevYearClose":86.02,"prevWeekClose":58.08,"prevMonthClose":69.44,"prevQuarterClose":69.44,"fiveDayClose":66.06,"twentyDayClose":75.33,"sixtyDayClose":87.97,"earningDate":1746547200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVO\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522340301","title":"Novo Nordisk's Wegovy Sales Growth Stalls in U.S. Amid Competition, Reimbursement Hurdles -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2522340301","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522340301?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:45","pubTimestamp":1743083100,"startTime":"0","endTime":"0","summary":"1344 GMT - Novo Nordisk sees flat U.S. weekly prescription rate growth for its obesity treatment Wegovy due to competition from U.S. rival Eli Lilly and compounding pharmacies, coupled with reimbursement challenges, Morgan Stanley analysts say. The Danish pharmaceutical company could trim its sales guidance, possibly alongside its 1Q results, due to the slower U.S. prescription growth, they say. While long-term forecasts still indicate potential upside, the future of the obesity market, peak sales potential and longevity of Novo Nordisk's weight loss drug portfolio remain uncertain, they add. The analysts also cite Eli Lilly's market share gains in the U.S. and product differentiation, including greater weight loss and better tolerability. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"gpt_icon":1},{"id":"2522399173","title":"Market Chatter: Novo Nordisk Settles Federal Lawsuit Over Insulin Prices in Minnesota","url":"https://stock-news.laohu8.com/highlight/detail?id=2522399173","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522399173?lang=en_us&edition=fundamental","pubTime":"2025-03-27 02:17","pubTimestamp":1743013052,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) settlement on the out-of-pocket price cap of insulin for Minnesota residents at $35 per month for the next five years was approved by a federal court in New Jersey, Bloomberg report","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7104","LU0154236417.USD","NVO","NVO.AU","IE00BKVL7J92.USD","US5Y.BOND","US2Y.BOND","US10Y.BOND","LU1093756168.USD","US3Y.BOND","US30Y.BOND","BK4585","US7Y.BOND","BK4532","US6M.BOND","US12M.BOND","BK4007","BK4599","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588"],"gpt_icon":1},{"id":"2522988420","title":"GLP-1s are driving returns on R&D investments for Big Pharma, report says","url":"https://stock-news.laohu8.com/highlight/detail?id=2522988420","media":"Quartz","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522988420?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:26","pubTimestamp":1742927160,"startTime":"0","endTime":"0","summary":"In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. - Image: Mario Tama / Staff . Big Pharma is expected to see big returns from its investment in a class of drugs made famous by Novo Nordisk’s  popular diabetes drug Ozempic.Deloitte’s annual report, Measuring the Return from Pharmaceutical Innovation, found that GLP-1 drugs could fuel significant returns on research and development investments made last year by major drugmakers. The consulting firm analyzed the projected internal rate of return for late-stage pipeline assets across the 20 leading pharma companies.GLP-1 drugs mimic hormones that regulate blood sugar and suppress appetite, making them highly sought after for treating obesity and Type 2 diabetes. The surging demand has propelled Eli Lilly  and Novo Nordisk into becoming the largest pharma companies in the world. Eli Lilly’s weight-loss drug Zepbound generated $4.9 billion in annual revenu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/glp-1s-driving-returns-r-182600084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1712237335.SGD","LU0689472784.USD","LU1623119135.USD","LU0823416689.USD","LU0154236417.USD","IE0004445239.USD","LU2357305700.SGD","LU2237443465.HKD","LU2468319806.SGD","BK4581","LU2461242641.AUD","SGXZ99366536.SGD","LU0094547139.USD","LU1093756325.SGD","LU1267930730.SGD","LU1974910355.USD","LU0256863902.USD","NVO","SG9999018857.SGD","LU0820561909.HKD","LU0096364046.USD","LLY","SG9999018865.SGD","LU2237443549.SGD","LU2063271972.USD","GLP","LU0385154629.USD","BK4516","LU2602419157.SGD","LU1291159041.SGD","LU0417517546.SGD","LU1551013425.SGD","BK4590","LU2265009873.SGD","LU0097036916.USD","SG9999015978.USD","LU0109391861.USD","LU2324357040.USD","SG9999015986.USD","LU1720051108.HKD","LU1868837136.USD","IE00BK4W5M84.HKD","LU1061106388.HKD","LU1989771016.USD","LU0203202063.USD","LU1366192091.USD","LU2023250504.SGD","SG9999015952.SGD","SG9999014914.USD","LU2264538146.SGD"],"gpt_icon":1},{"id":"2522503026","title":"This Company Just Overtook Ozempic Maker Novo Nordisk as Europe's Most Valuable -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2522503026","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522503026?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:25","pubTimestamp":1742901900,"startTime":"0","endTime":"0","summary":"Novo Nordisk is no longer the king of publicly-listed European companies.The Ozempic maker's Copnehagen-listed stock slipped 1.3%, Monday to take its total market capitalization to  just under 2.33 trillion Danish kroner , according to Dow Jones Market Data.That meant that SAP took its crown. The German software company's Frankfurt-listed shares rose 1.3% Monday to lift its total market cap to 313.70 billion euros .The two stocks have been moving in different directions for months -- and that says something about the broader market. Novo has plummeted 41% over the past year as the weight-loss drugs boom has fizzled out, while SAP has risen by the same amount.It's benefited from the artificial-intelligence investing craze, which is expected to boost revenue for its cloud-computing division, as well as a broader rotation from U.S. to European stocks amid worries that President Donald Trump's tariffs will fuel a flare-up in inflation and drag down growth.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","MKR.USD.CC","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4528","SAP","LU0154236417.USD","LU1093756168.USD","MKR.USD.HKCC","LU1093756325.SGD","BK4585","BK4007","BK4588","BK4532","BK4613","BK4023","NVO"],"gpt_icon":1},{"id":"2522028530","title":"Trump Tariff Uncertainty Will Break This Stock Market Calm, Brace for Another Storm. And 5 Other Things to Know Today. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2522028530","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522028530?lang=en_us&edition=fundamental","pubTime":"2025-03-25 18:56","pubTimestamp":1742900160,"startTime":"0","endTime":"0","summary":"A sense of calm has returned to the stock market, at least relative to the volatility of President Donald Trump's second term so far.Wall Street's fear gauge -- the CBOE Volatility Index  -- fell to its lowest level in more than a month while the S&P 500 moved back above its 200-day moving average Monday for the first time since March 7.But is the abrupt return to tranquility warranted?It seems the tariffs imposed on Trump's so-called Liberation Day next week won't be as severe as feared. \"I may give a lot of countries breaks, \" Trump said, referring to plans for reciprocal tariffs. It comes after he said sector-specific levies on autos, semiconductors, and pharmaceuticals may not take effect until later.That understandably justifies a degree of relief among investors, but we've been here before and tariff uncertainty hasn't gone away -- far from it.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["81211","LU0098860793.USD","LU2129689514.USD","LU2249611893.SGD","BK4574","LU0359201612.USD","LU0175139822.USD","TSLL","CVX","NVO","IE00BGHQF524.EUR","BK0188","LU0368265418.SGD","LU1861219969.SGD","LU2023250504.SGD","BK1540","LU2468319806.SGD","LU0359202008.SGD","BYDDY","LU1989771016.USD","LU2097828557.USD","SG9999017495.SGD","LU0572944931.SGD","LU0278409577.USD","LU0084288322.USD","LU1093756168.USD","LU0511384066.AUD","LU0823411888.USD","HYDD.SI","LU0823426308.USD","SGXZ81514606.USD","LU0300736062.USD","SG9999001226.SGD","LU0289961442.SGD","LU1162221912.USD","LU2471134879.HKD","LU2237443465.HKD","LU0345770308.USD","SGXZ99366536.SGD","LU0300736492.USD","TSYW.SI","LU2756315318.SGD","IE00BJT1NW94.SGD","LLY","TSLA","EVS.SI","LU0943347566.SGD","LU0417517546.SGD"],"gpt_icon":1},{"id":"2522052598","title":"GLP-1s boosts pharma R&D projected return on investment: Deloitte","url":"https://stock-news.laohu8.com/highlight/detail?id=2522052598","media":"Yahoo Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522052598?lang=en_us&edition=fundamental","pubTime":"2025-03-25 12:00","pubTimestamp":1742875241,"startTime":"0","endTime":"0","summary":"Popular diabetes and weight-loss drugs known as GLP-1s are helping to boost the biopharma sector's return on investment this year, according to a new report from consulting firm Deloitte.Companies that are developing drug candidates that could compete with the two market leaders, Novo Nordisk  and Eli Lilly , and their blockbuster weight-loss and diabetes drugs are adding more value to research in the sector, said Deloitte.The report shows the R&D returns for 2024 were 5.9%, up from 4.1% in 2023. Without GLP-1s, the returns for R&D would have dropped to 3.8% in 2024.ROI isn't the only area in which GLP-1s are boosting the sector. Peak sales forecasts are also benefiting. Average peak sales projected per asset have increased to $510 million. But without GLP-1s, that average drops to $370 million.Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics. That includes GLP-1s,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/glp-1s-boosts-pharma-rd-projected-return-on-investment-deloitte-040041685.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999015978.USD","LU0006306889.USD","LU1069344957.HKD","LU0354030438.USD","LU1280957306.USD","IE00BK4W5M84.HKD","IE00BK4W5L77.USD","SG9999014914.USD","LU1814569148.SGD","GLP","LU0882574139.USD","LU1093756168.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2023250504.SGD","SG9999014880.SGD","LU0097036916.USD","SG9999015952.SGD","BK4516","LU2265009873.SGD","LU0640476718.USD","IE0002141913.USD","LU1127390331.HKD","SG9999018865.SGD","SG9999014898.SGD","LU1988902786.USD","LU1551013425.SGD","LU2461242641.AUD","LU0385154629.USD","LU1551013342.USD","LLY","LU2491050071.SGD","NVO","SG9999015945.SGD","LU2357305700.SGD","LU2237443895.HKD","LU1989771016.USD","LU1868837300.USD","LU2237443465.HKD","LU0154236417.USD","SGXZ31699556.SGD","BK4007","SG9999018857.SGD","BK4599","LU0672654240.SGD","LU1093756325.SGD","LU0203201768.USD","IE0004445239.USD","IE00BFTCPJ56.SGD"],"gpt_icon":1},{"id":"2522567052","title":"Is Novo Nordisk A/S (NYSE:NVO) The Best Extremely Profitable Stocks to Buy According to Analyst?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522567052","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522567052?lang=en_us&edition=fundamental","pubTime":"2025-03-25 11:42","pubTimestamp":1742874139,"startTime":"0","endTime":"0","summary":"We recently published a list of 11 Best Extremely Profitable Stocks to Buy According to Analysts. In this article, we are going to take a look at where Novo Nordisk A/S  stands against other best extremely profitable stocks to buy according to analysts.We recently covered10 Best Stocks to Buy Now For the Long Term,where we talked about the market outlook amidst the tariff situation and uncertainty. Here’s a piece from the article:. Dwyer also highlighted the Fed’s decision to slow quantitative tightening by reducing its monthly cap on US Treasury redemptions from $25 billion to $5 billion starting in April. This move aligns with the broader e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-nyse-nvo-best-034219868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4599","IE00BKVL7J92.USD","US7Y.BOND","US2Y.BOND","US5Y.BOND","LU0154236417.USD","LU1093756325.SGD","BK4007","US6M.BOND","LU1093756168.USD","US30Y.BOND","NVO","BK4532","NYSE","US3Y.BOND","IE00BZ1G4Q59.USD","BK4585","US10Y.BOND","US12M.BOND"],"gpt_icon":1},{"id":"2522477015","title":"Novo Nordisk A/S Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2522477015","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522477015?lang=en_us&edition=fundamental","pubTime":"2025-03-25 01:03","pubTimestamp":1742835780,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S shed 1.3% to DKK521.70 Monday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.3% to 2,511.35.This was the stock's fourth consecutive day of losses.The company closed DKK511.50 short of its 52-week high of DKK1,033.20, which the company reached on June 26, 2024.Trading volume was 3,452,262, compared to the 50-day average trading volume of 4,820,591.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"gpt_icon":1},{"id":"2522777111","title":"Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped","url":"https://stock-news.laohu8.com/highlight/detail?id=2522777111","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522777111?lang=en_us&edition=fundamental","pubTime":"2025-03-25 00:44","pubTimestamp":1742834640,"startTime":"0","endTime":"0","summary":"There's a price war brewing in GLP-1 weight loss drugs, and now it's going global.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/24/novo-stock-dropped-eli-lilly-and-hims-hers-popped/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1551013425.SGD","LU0471298694.HKD","LU0094547139.USD","BK4581","LU0417517546.SGD","NVO","LU2361044949.HKD","LU0096364046.USD","LU0238689110.USD","LU0820561818.USD","LU1623119135.USD","LU2491050071.SGD","LU1814569148.SGD","LU0882574139.USD","LU0820561909.HKD","LU1291159041.SGD","IE0002141913.USD","BK4585","LU1720051108.HKD","LU0466842654.USD","LU2357305700.SGD","SG9999013999.USD","SG9999017495.SGD","LU0320765059.SGD","SGXZ51526630.SGD","LU2361044865.SGD","LLY","IE00BKVL7J92.USD","LU2360106947.USD","LU0882574055.USD","SG9999014898.SGD","LU2491050154.USD","IE00BK4W5M84.HKD","LU2211815571.USD","LU2237443465.HKD","LU1868837300.USD","LU1069344957.HKD","LU0943347566.SGD","LU1989771016.USD","SG9999014906.USD","LU2461242641.AUD","SG9999018865.SGD","SGXZ57979304.SGD","LU2063271972.USD","LU0106261372.USD","LU0456855351.SGD","LU1974910355.USD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4588"],"gpt_icon":1},{"id":"2521472074","title":"Novo Nordisk Expands Wegovy Savings Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2521472074","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521472074?lang=en_us&edition=fundamental","pubTime":"2025-03-24 22:24","pubTimestamp":1742826251,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Monday it will now allow cash-paying patients access to Wegovy injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg at local pharmacies for a reduced cost of $499 per month following updates to its Wegovy savings program.The $499-per-month offer for Wegovy was only available via the recently launched NovoCare Pharmacy, the company said.Price: 75.29, Change: -1.57, Percent Change: -2.04","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO","IE00BKVL7J92.USD","BK4599","NVO.AU","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU0154236417.USD","BK4585","BK4588","BK4532","LU1093756168.USD","BK7104","BK4007"],"gpt_icon":1},{"id":"2521992723","title":"Deutsche Bank  Keeps Their Buy Rating on Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521992723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521992723?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:35","pubTimestamp":1742819734,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK900.00...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-keeps-their-buy-rating-on-novo-nordisk-0qiu-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-keeps-their-buy-rating-on-novo-nordisk-0qiu-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DB","NVO"],"gpt_icon":0},{"id":"2521728550","title":"Novo Nordisk expands Wegovy® $499-per-month offering to additional cash-paying patients via the Wegovy® savings offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2521728550","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521728550?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:00","pubTimestamp":1742817600,"startTime":"0","endTime":"0","summary":"The Wegovy savings offer is good for all dose strengths of Wegovy. \"At Novo Nordisk, we are committed to developing innovative medicines and will continue to prioritize making them accessible to and affordable for the communities we serve,\" said Dave Moore, Executive Vice President, U.S. Operations and Global Business Development and President of Novo Nordisk Inc. \"With the evolution of our Wegovy savings program, we continue to deliver options that empower people living with obesity to more easily pursue their weight management and health goals.\". About the Wegovy savings offer The Wegovy savings offer gives cash-paying patients or those with commercial insurance that does not cover obesity medicines access to a 28-day supply  of Wegovy for $499. This updated offer replaces the previous Wegovy savings offer, which provided cash-paying patients access to Wegovy at a cost of $650 per month. Patients enrolled in government-funded healthcare programs are not eligible for these savings off","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/novo-nordisk-expands-wegovy-499-120000651.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-expands-wegovy-499-120000651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756168.USD","BK4023","LU0154236417.USD","MTC","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","BK4599","BK4007","BK4532","IE00BKVL7J92.USD","BK4588"],"gpt_icon":1},{"id":"2521463742","title":"Novo Nordisk Signs $2 Billion Deal for Experimental Obesity Drug -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2521463742","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521463742?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:55","pubTimestamp":1742817300,"startTime":"0","endTime":"0","summary":"Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese pharmaceutical company the United Bio-Technology  Co., as it looks to boost its pipeline of next-generation drugs.Novo Nordisk, which earlier Monday lost its crown as Europe's most valuable company, said it signed an exclusive global licensing deal for UBT251, a drug that targets three different hormones to treat obesity, type 2 diabetes, and other diseases.The Danish pharmaceutical company will pay $200 million up front and potential milestone payments of up to $1.8 billion, as well as tiered royalties.Novo Nordisk has exclusive rights to develop, manufacture, and commercialize UBT251 globally, excluding the Chinese mainland, Hong Kong, Macau and Taiwan.UBT251 differs from Novo Nordisk's current portfolio as it takes a three-pronged approach to weight-loss and blood-sugar control. It combines a GLP-1--the same class of drugs as Novo Nordisk's blockbuster Wegovy and O","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4007","NVO","ULIHF","BK4585","BK4599","03933","IE00BKVL7J92.USD","LU1093756168.USD","BK1191","BK4532"],"gpt_icon":1},{"id":"2521674404","title":"Novo Nordisk to Pay Up to $2 Billion to License Chinese Company's Weight-Loss Drug -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2521674404","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521674404?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:42","pubTimestamp":1742816520,"startTime":"0","endTime":"0","summary":"Novo Nordisk said Monday that it had entered into a license agreement with a Chinese company developing a competitor to Novo's Ozempic.The Danish pharma giant said it would pay $200 million upfront and up to $1.8 billion in milestone payments to United Laboratories International for the rights to UBT251, a drug in early-stage clinical development for the treatment of type 2 diabetes, obesity, and other diseases.UBT251 is what's known as a \"triple agonist.\" It binds to the body's receptors for GLP-1, GIP, and glucagon, mimicking the effects of the hormones to manage blood sugar levels and promote insulin secretion.United Biotechnology, a subsidiary wholly owned by United Laboratories International, will retain the rights for UBT251 in the Chinese mainland, Hong Kong, Macau, and Taiwan. Novo Nordisk will be granted exclusive rights to develop, manufacture, and commercialize the drug elsewhere.Novo Nordisk is currently a leader in the U.S. market for GLP-1 drugs. The company is the maker ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novo Nordisk to Pay Up to $2 Billion to License Chinese Company's Weight-Loss Drug -- Barrons.com","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"gpt_icon":1},{"id":"2521726042","title":"5 Low-Leverage Stocks to Buy Amid Trump's Tariff Woes","url":"https://stock-news.laohu8.com/highlight/detail?id=2521726042","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521726042?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:27","pubTimestamp":1742815620,"startTime":"0","endTime":"0","summary":"The majority of U.S. stock indices ended barely in the green on March 21, 2025, overcoming their recent losing streaks since investors remain wary about the long-term economic impacts of President Trump’s enhanced import tariffs. The latest uptick in the major stock indices was mostly because the Federal Reserve kept its projection for interest rate cuts broadly unchanged, indicating economic stability for the time being.This might attract investors to invest in the stock market. However, considering the fact that the global stock market has seen major ups and downs in recent times, a prudent investor knows that to avoid big losses during a crisis, one should choose safe bet stocks like BioLife Solutions BLFS, Wildan Group WLDN, Nextracker Inc. NXT, Novo Nordisk NVO and EZCORP EZPW. These stocks bear low leverage and, therefore, should be a safer option for investors if they don’t want to lose big in times of market turmoil.To identify such stocks, historically, several leverage ratios","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/5-low-leverage-stocks-buy-112700955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2249611893.SGD","LU0124384867.USD","LU0154236417.USD","NVO","BK4198","LU0823414478.USD","BK4166","BLFS","LU2506951792.HKD","BK4596","LU1169589451.USD","IE00BKVL7J92.USD","LU0823414551.USD","LU1093756168.USD","WLDN","BK4121","LU1978683503.SGD","LU1169590202.USD","LU2294711713.HKD","BK4585","BK4532","NXT","BK4096","LU1983299162.USD","BK4007","BK4599","LU0724618433.USD","LU2298322129.HKD","LU2357125470.USD","EZPW","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588","BK4123","USD"],"gpt_icon":1},{"id":"2521741998","title":"Novo Nordisk to Pay up to $2 Billion for Rights to Developmental Obesity, Diabetes Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2521741998","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521741998?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:25","pubTimestamp":1742815529,"startTime":"0","endTime":"0","summary":"Novo Nordisk to Pay up to $2 Billion for Rights to Developmental Obesity, Diabetes Drug","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","LU0154236417.USD","LU1093756168.USD","NVO","BK4585","IE00BZ1G4Q59.USD","BK4599","BK4532","BK4007","BK4588","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2521538745","title":"Novo Nordisk strikes $2 billion deal with a Chinese company making a GLP-1 drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2521538745","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521538745?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:55","pubTimestamp":1742813700,"startTime":"0","endTime":"0","summary":"Novo Nordisk announced Monday a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the Danish company is currently the leading player.Novo Nordisk said it's paying $200 million upfront and up to $1.8 billion in milestone payments to United Laboratories International for the right to license a drug, outside of China that is in early-stage development to treat obesity, Type 2 diabetes and other diseases.The candidate, currently called UBT251, is what's called a triple agonist of the receptors for GLP-1, GIP, and glucagon. In a Phase 1 trial, the highest dose group achieved an average weight loss of 15.1%, compared with 1.5% for the placebo.Behind the Ozempic and Wegovy drugs to treat diabetes and weight loss, Novo Nordisk became Europe's top company by market cap, though it's now fallen from that perch.Novo Nordisk shares   fell 3% on Monday and have dropped 18% this year, as the Danish drugmaker's trial of a key next-generation drug disappointed investors","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4590","BK1191","03933","BK4585","BK4144","GLP","BK4588","ULIHF","BK4599","BK4007","LU1093756325.SGD","BK4532","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2521743604","title":"Germany's SAP Overtakes Wegovy Maker Novo Nordisk as Europe's Most Valuable Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2521743604","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521743604?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:44","pubTimestamp":1742813040,"startTime":"0","endTime":"0","summary":"German business-software group SAP claimed the top spot as Europe's largest company by market value, dethroning Danish pharmaceutical giant Novo Nordisk.SAP shares in Frankfurt rose more than 0.5% on Monday, lifting the group's market value to 312.9 billion euros . Meanwhile, Novo Nordisk shares in Copenhagen shed more than 2.5%, taking the company's market value to nearly 2.31 trillion Danish kroner .SAP's ascent comes as Chief Executive Christian Klein doubles down on his strategy to move away from software-licenses sales in favor of subscription-based cloud services, banking on a more profitable and predictable model based on recurring revenue.The group in January lifted its operating profit and sales guidance for the year as it expects strong growth at its core cloud business to accelerate, aided by the appeal of artificial intelligence.SAP stock is up more than 40% over the past 12 months, contributing to growth in Germany's DAX index, which is up more than 26%. In contrast, Novo ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","BK4613","SAP","BK4585","MKR.USD.CC","BK4528","BK4023","BK4588","MKR.USD.HKCC"],"gpt_icon":1},{"id":"2521717557","title":"Novo Nordisk's Ozempic Drug Faces Declining Sales -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2521717557","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521717557?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:19","pubTimestamp":1742811540,"startTime":"0","endTime":"0","summary":"1019 GMT - Novo Nordisk's diabetes treatment Ozempic faces falling sales amid U.S. share loss and price declines, Intron Health analysts write. \"New analysis makes us more concerned about Ozempic 2025 sales, than Wegovy. We are now 8% below the mid-point of [group] 2025 guidance on sales and EBIT.\" Intron Helath is 40% below 2030 consensus Ozempic sales, which could translate to a 16% cut to 2030 consensus group EBIT. The analysts suggest a profit warning is possible at or before first quarter results on May 7. However, results from a trial testing semaglutide as a treatment for Alzheimer's due this year \"could be game changing.\" Intron Helath downgrades Novo to sell from buy and lowers its target price to 460 Danish kroner from 880 kroner. Shares fall 2.6% to 515.00 kroner. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"gpt_icon":1},{"id":"2521743606","title":"The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist","url":"https://stock-news.laohu8.com/highlight/detail?id=2521743606","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521743606?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:02","pubTimestamp":1742810520,"startTime":"0","endTime":"0","summary":"Guangdong, China and Bagsvrd, Denmark, 24 March 2025 –The United Laboratories International Holdings Limited  and Novo Nordisk A/S  today announced that Novo Nordisk and TUL’s wholly-owned subsidiary The United Bio-Technology  Co., Ltd. , have entered into an exclusive license agreement for UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon in early-stage clinical development for the treatment of obesity, type 2 diabetes, and other diseases.“We are pleased to announce our exclusive license agreement with Novo Nordisk for UBT251. As a leading global biopharmaceutical company, Novo Nordisk holds a strong position in the treatment of chronic diseases,” said Mr. Tsoi Hoi Shan, the Chairman of TUL. “TUL is committed to strengthening its presence in the treatm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/united-laboratories-novo-nordisk-announce-100200123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4590","IE00BKVL7J92.USD","LU1093756168.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4211","BK4585","BK4007","BK4144","GLP","LU1093756325.SGD","UBCP","BK4599","NVO","BK4532"],"gpt_icon":1}],"pageSize":20,"totalPage":20,"pageCount":6,"totalSize":400,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVO\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"NVO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.91,"defaultRemindTime":1746604800000,"name":null,"time":"Pre-Market","dateTimestamp":1746590400000,"actualEps":null},{"date":"2025-03-31","symbol":"NVO","amount":1.09921,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-31","defaultRemindTime":1743427800000,"name":"诺和诺德","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-08","payableDate":"2025-03-31","currency":"USD","dateTimestamp":1743393600000,"payDate":"2025-04-08"},{"market":"US","date":"2025-02-05","symbol":"NVO","fiscalQuarterEnding":"2024/12","expectedEps":0.83,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738731600000,"reportTimeType":"pre","actualEps":0.91},{"market":"US","date":"2024-11-06","symbol":"NVO","fiscalQuarterEnding":"2024/09","expectedEps":0.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":0.9},{"date":"2024-08-16","symbol":"NVO","amount":0.5126402,"announcedDate":"2024-08-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-16","defaultRemindTime":1723815000000,"name":"诺和诺德","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-26","payableDate":"2024-08-16","currency":"USD","dateTimestamp":1723780800000,"payDate":"2024-08-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVO\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-30","value":0.699443,"currency":"USD"},{"executeDate":"2016-08-11","recordDate":"2016-08-15","paymentDate":"2016-08-23","value":0.331026,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-04-04","value":0.479369,"currency":"USD"},{"executeDate":"2017-08-17","recordDate":"2017-08-21","paymentDate":"2017-08-29","value":0.335753,"currency":"USD"},{"executeDate":"2017-08-18","recordDate":"2017-08-21","paymentDate":"2017-08-29","value":0.335753,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.4,"hold":0.3333,"sell":0,"strongSell":0.0667,"meanLabel":"BUY","meanPercent":0.4,"analysts":15,"updateTime":1745121600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NVO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NVO","date":"2025-04-17","current":18.516566,"percent":0.002433,"low":17.756123,"twenty":25.17357,"median":35.432631,"eighty":42.141973,"high":49.958416,"avg":34.665015,"sd":7.807516,"marketCap":284856366575.72},"quantilePoints":[{"date":"2020-04-24","current":26.867421,"twenty":18.894428,"median":20.079477,"eighty":21.907483,"marketCap":151545104532.4},{"date":"2020-05-01","current":25.955394,"twenty":18.895849,"median":20.087864,"eighty":21.978532,"marketCap":149255788342.56},{"date":"2020-05-08","current":25.051001,"twenty":18.906558,"median":20.094237,"eighty":22.005976,"marketCap":147275632655.31},{"date":"2020-05-15","current":25.409708,"twenty":18.912406,"median":20.101278,"eighty":22.0296,"marketCap":148873463092.12},{"date":"2020-05-22","current":25.872228,"twenty":18.912629,"median":20.123954,"eighty":22.063654,"marketCap":152694221841.1},{"date":"2020-05-29","current":25.214058,"twenty":18.914534,"median":20.149096,"eighty":22.16643,"marketCap":152054422411.2},{"date":"2020-06-05","current":24.81723,"twenty":18.918665,"median":20.160906,"eighty":22.207177,"marketCap":152106950250.68},{"date":"2020-06-12","current":24.967462,"twenty":18.920381,"median":20.181556,"eighty":22.293977,"marketCap":152137118068.5},{"date":"2020-06-19","current":25.953133,"twenty":18.921665,"median":20.208932,"eighty":22.344279,"marketCap":157406588494.26},{"date":"2020-06-26","current":25.41017,"twenty":18.927007,"median":20.222925,"eighty":22.368966,"marketCap":154425521338.95},{"date":"2020-07-02","current":25.387131,"twenty":18.930302,"median":20.237258,"eighty":22.454741,"marketCap":154716035044.13},{"date":"2020-07-10","current":24.928281,"twenty":18.932061,"median":20.244736,"eighty":22.618377,"marketCap":152965572667.12},{"date":"2020-07-17","current":25.127545,"twenty":18.934284,"median":20.248617,"eighty":22.717096,"marketCap":155883422581.28},{"date":"2020-07-24","current":24.48432,"twenty":18.935585,"median":20.254723,"eighty":22.918823,"marketCap":154675327844.66},{"date":"2020-07-31","current":24.047966,"twenty":18.940507,"median":20.277143,"eighty":23.068391,"marketCap":154231394914.19},{"date":"2020-08-07","current":22.873108,"twenty":18.962048,"median":20.286764,"eighty":23.098802,"marketCap":150039892807.22},{"date":"2020-08-14","current":23.351095,"twenty":18.97422,"median":20.297567,"eighty":23.129564,"marketCap":153696547258.82},{"date":"2020-08-21","current":23.506307,"twenty":18.97422,"median":20.338835,"eighty":23.173103,"marketCap":154147099905.35},{"date":"2020-08-28","current":23.233813,"twenty":18.976693,"median":20.346449,"eighty":23.199328,"marketCap":153902794177.21},{"date":"2020-09-04","current":22.975477,"twenty":18.979696,"median":20.359122,"eighty":23.203533,"marketCap":150923104804.78},{"date":"2020-09-11","current":23.492497,"twenty":18.980624,"median":20.379539,"eighty":23.221624,"marketCap":154858249083.45},{"date":"2020-09-18","current":24.430548,"twenty":18.980813,"median":20.408133,"eighty":23.259229,"marketCap":161415364546.47},{"date":"2020-09-25","current":24.671829,"twenty":18.987374,"median":20.422343,"eighty":23.293451,"marketCap":159465969885.43},{"date":"2020-10-02","current":24.503203,"twenty":18.99947,"median":20.465963,"eighty":23.341957,"marketCap":159867917489.8},{"date":"2020-10-09","current":25.468325,"twenty":19.006376,"median":20.476897,"eighty":23.376076,"marketCap":167575953324.27},{"date":"2020-10-16","current":25.367025,"twenty":19.012629,"median":20.495458,"eighty":23.433966,"marketCap":165474367315.48},{"date":"2020-10-23","current":24.977035,"twenty":19.016381,"median":20.509253,"eighty":23.478521,"marketCap":164690165254.72},{"date":"2020-10-30","current":22.964768,"twenty":19.01811,"median":20.523682,"eighty":23.497462,"marketCap":149317905417.56},{"date":"2020-11-06","current":24.836576,"twenty":19.01811,"median":20.557138,"eighty":23.512582,"marketCap":164585520531.77},{"date":"2020-11-13","current":23.92135,"twenty":19.018151,"median":20.586004,"eighty":23.556384,"marketCap":157749938193.53},{"date":"2020-11-20","current":23.798479,"twenty":19.018905,"median":20.596668,"eighty":23.559097,"marketCap":157395701186.22},{"date":"2020-11-27","current":23.366057,"twenty":19.020013,"median":20.62528,"eighty":23.557037,"marketCap":155953935937.08},{"date":"2020-12-04","current":23.128769,"twenty":19.02074,"median":20.635044,"eighty":23.548046,"marketCap":156651229493.06},{"date":"2020-12-11","current":23.741089,"twenty":19.024249,"median":20.65426,"eighty":23.559566,"marketCap":160498031078.69},{"date":"2020-12-18","current":24.859864,"twenty":19.032057,"median":20.684505,"eighty":23.60196,"marketCap":169745752365.84},{"date":"2020-12-24","current":23.71641,"twenty":19.035885,"median":20.691944,"eighty":23.647275,"marketCap":161362260340.54},{"date":"2020-12-31","current":23.752597,"twenty":19.043669,"median":20.700113,"eighty":23.655219,"marketCap":162141509961.91},{"date":"2021-01-08","current":23.696925,"twenty":19.054553,"median":20.702874,"eighty":23.669838,"marketCap":162085386745.31},{"date":"2021-01-15","current":24.63696,"twenty":19.057389,"median":20.716876,"eighty":23.708595,"marketCap":166433622652.22},{"date":"2021-01-22","current":24.733507,"twenty":19.062993,"median":20.723709,"eighty":23.71641,"marketCap":168128182581.6},{"date":"2021-01-29","current":23.66534,"twenty":19.066991,"median":20.74808,"eighty":23.736593,"marketCap":160442919521.41},{"date":"2021-02-05","current":24.144958,"twenty":19.074243,"median":20.76778,"eighty":23.752597,"marketCap":164540849620.52},{"date":"2021-02-12","current":25.225531,"twenty":19.07899,"median":20.797565,"eighty":23.777504,"marketCap":173229483939.31},{"date":"2021-02-19","current":24.959325,"twenty":19.081317,"median":20.799559,"eighty":23.806962,"marketCap":171627664948},{"date":"2021-02-26","current":24.004919,"twenty":19.093638,"median":20.862145,"eighty":23.873811,"marketCap":164489659329.96},{"date":"2021-03-05","current":23.404671,"twenty":19.111181,"median":20.875532,"eighty":23.905889,"marketCap":157942482529.58},{"date":"2021-03-12","current":24.089101,"twenty":19.119294,"median":20.889746,"eighty":23.962573,"marketCap":163024135663.81},{"date":"2021-03-19","current":24.138081,"twenty":19.123295,"median":20.904372,"eighty":23.998671,"marketCap":162830497921.9},{"date":"2021-03-26","current":23.193081,"twenty":19.125783,"median":20.915881,"eighty":23.998671,"marketCap":155028423557.96},{"date":"2021-04-01","current":23.52667,"twenty":19.127286,"median":20.926203,"eighty":23.993088,"marketCap":156817423018.8},{"date":"2021-04-09","current":23.983791,"twenty":19.130007,"median":20.934547,"eighty":23.982077,"marketCap":161500891836.66},{"date":"2021-04-16","current":24.585509,"twenty":19.135369,"median":20.954088,"eighty":24.003818,"marketCap":166924602982.29},{"date":"2021-04-23","current":24.888444,"twenty":19.154229,"median":20.969625,"eighty":24.029256,"marketCap":170123633615.16},{"date":"2021-04-30","current":24.781152,"twenty":19.168299,"median":20.983334,"eighty":24.05937,"marketCap":168940260884.15},{"date":"2021-05-07","current":24.862287,"twenty":19.168313,"median":21.002289,"eighty":24.103706,"marketCap":174111030297.4},{"date":"2021-05-14","current":25.680125,"twenty":19.169922,"median":21.008477,"eighty":24.13588,"marketCap":179619740292.48},{"date":"2021-05-21","current":26.638996,"twenty":19.176658,"median":21.021183,"eighty":24.190726,"marketCap":187115548928.29},{"date":"2021-05-28","current":25.873568,"twenty":19.178877,"median":21.040438,"eighty":24.263308,"marketCap":181800162428.55},{"date":"2021-06-04","current":26.345582,"twenty":19.179319,"median":21.053853,"eighty":24.285624,"marketCap":184775704703.34},{"date":"2021-06-11","current":27.692274,"twenty":19.199433,"median":21.083723,"eighty":24.344734,"marketCap":193163556543.63},{"date":"2021-06-18","current":27.562609,"twenty":19.208025,"median":21.096166,"eighty":24.361441,"marketCap":188360125172.74},{"date":"2021-06-25","current":27.369088,"twenty":19.210647,"median":21.103168,"eighty":24.421966,"marketCap":188446101585.45},{"date":"2021-07-02","current":28.401996,"twenty":19.210647,"median":21.114662,"eighty":24.435013,"marketCap":193982287498.47},{"date":"2021-07-09","current":29.15552,"twenty":19.214303,"median":21.129655,"eighty":24.468615,"marketCap":199245918791.31},{"date":"2021-07-16","current":29.748027,"twenty":19.217292,"median":21.161518,"eighty":24.490561,"marketCap":202423046447.21},{"date":"2021-07-23","current":30.548898,"twenty":19.221453,"median":21.201939,"eighty":24.511382,"marketCap":207131156155.73},{"date":"2021-07-30","current":31.028871,"twenty":19.231278,"median":21.213607,"eighty":24.569151,"marketCap":212047874609.99},{"date":"2021-08-06","current":32.395633,"twenty":19.235828,"median":21.24031,"eighty":24.602335,"marketCap":227314943084.39},{"date":"2021-08-13","current":33.444654,"twenty":19.245768,"median":21.264014,"eighty":24.618734,"marketCap":235357755572.42},{"date":"2021-08-20","current":35.162284,"twenty":19.252624,"median":21.284091,"eighty":24.637948,"marketCap":245024372447.53},{"date":"2021-08-27","current":33.317228,"twenty":19.254232,"median":21.299761,"eighty":24.664571,"marketCap":234227686615.91},{"date":"2021-09-03","current":32.51607,"twenty":19.257876,"median":21.307766,"eighty":24.680091,"marketCap":230459438672.73},{"date":"2021-09-10","current":32.4019,"twenty":19.265781,"median":21.308587,"eighty":24.70983,"marketCap":228661682182.4},{"date":"2021-09-17","current":33.217031,"twenty":19.275643,"median":21.31816,"eighty":24.748523,"marketCap":232556230491.03},{"date":"2021-09-24","current":33.133852,"twenty":19.28101,"median":21.366025,"eighty":24.781525,"marketCap":231485444596.91},{"date":"2021-10-01","current":31.636526,"twenty":19.282323,"median":21.379396,"eighty":24.807401,"marketCap":218723923570.81},{"date":"2021-10-08","current":32.62123,"twenty":19.292246,"median":21.424335,"eighty":24.819271,"marketCap":225023326184.09},{"date":"2021-10-15","current":33.946197,"twenty":19.300615,"median":21.441679,"eighty":24.850379,"marketCap":234792449901.15},{"date":"2021-10-22","current":34.940645,"twenty":19.305339,"median":21.46446,"eighty":24.869112,"marketCap":242391720236.88},{"date":"2021-10-29","current":36.321794,"twenty":19.317085,"median":21.481952,"eighty":24.910826,"marketCap":250286576656.34},{"date":"2021-11-05","current":35.845468,"twenty":19.323924,"median":21.485165,"eighty":24.933393,"marketCap":257225403187.95},{"date":"2021-11-12","current":36.23085,"twenty":19.331676,"median":21.507417,"eighty":24.958198,"marketCap":257608851210.18},{"date":"2021-11-19","current":37.116824,"twenty":19.345306,"median":21.532015,"eighty":24.979469,"marketCap":260887858225.31},{"date":"2021-11-26","current":35.192364,"twenty":19.356984,"median":21.55377,"eighty":25.007968,"marketCap":247253528775.96},{"date":"2021-12-03","current":34.779718,"twenty":19.366605,"median":21.564829,"eighty":25.025535,"marketCap":244009518773.87},{"date":"2021-12-10","current":37.077467,"twenty":19.368252,"median":21.595944,"eighty":25.051001,"marketCap":260567603896.15},{"date":"2021-12-17","current":37.755329,"twenty":19.370111,"median":21.624963,"eighty":25.075501,"marketCap":264426435053.61},{"date":"2021-12-23","current":35.286619,"twenty":19.372748,"median":21.642383,"eighty":25.088396,"marketCap":247857298298.99},{"date":"2021-12-31","current":36.268584,"twenty":19.377097,"median":21.651516,"eighty":25.114085,"marketCap":256200781628.71},{"date":"2022-01-07","current":32.760154,"twenty":19.38262,"median":21.653879,"eighty":25.128044,"marketCap":230720648818.99},{"date":"2022-01-14","current":30.818322,"twenty":19.384382,"median":21.68023,"eighty":25.174523,"marketCap":218443964635.68},{"date":"2022-01-21","current":31.136402,"twenty":19.385972,"median":21.684325,"eighty":25.195792,"marketCap":219146324970.82},{"date":"2022-01-28","current":31.503876,"twenty":19.386575,"median":21.723243,"eighty":25.219747,"marketCap":218258768785.68},{"date":"2022-02-04","current":30.817262,"twenty":19.390561,"median":21.761359,"eighty":25.239036,"marketCap":226341444546.24},{"date":"2022-02-11","current":31.24152,"twenty":19.399542,"median":21.802534,"eighty":25.330576,"marketCap":228662000445.22},{"date":"2022-02-18","current":31.558527,"twenty":19.430111,"median":21.831822,"eighty":25.373478,"marketCap":229660563546.04},{"date":"2022-02-25","current":32.080292,"twenty":19.441626,"median":21.877895,"eighty":25.39352,"marketCap":231766624360.89},{"date":"2022-03-04","current":33.411951,"twenty":19.4781,"median":21.910488,"eighty":25.42464,"marketCap":234164709693.38},{"date":"2022-03-11","current":33.00382,"twenty":19.489325,"median":21.991057,"eighty":25.570139,"marketCap":231731491493.28},{"date":"2022-03-18","current":35.330464,"twenty":19.508557,"median":22.016415,"eighty":25.682152,"marketCap":250798493290.2},{"date":"2022-03-25","current":34.179645,"twenty":19.556544,"median":22.061992,"eighty":25.744888,"marketCap":241158119197.15},{"date":"2022-04-01","current":36.167601,"twenty":19.58088,"median":22.185048,"eighty":25.853221,"marketCap":256312426005.84},{"date":"2022-04-08","current":39.273848,"twenty":19.604392,"median":22.28303,"eighty":25.888765,"marketCap":274208694671.97},{"date":"2022-04-14","current":38.556312,"twenty":19.612493,"median":22.335412,"eighty":25.976371,"marketCap":267248834742.15},{"date":"2022-04-22","current":36.480935,"twenty":19.640088,"median":22.368847,"eighty":26.056619,"marketCap":252572523875.96},{"date":"2022-04-29","current":37.41207,"twenty":19.651796,"median":22.515602,"eighty":26.132235,"marketCap":261449903437.4},{"date":"2022-05-06","current":35.97608,"twenty":19.656997,"median":22.648689,"eighty":26.232232,"marketCap":252755242643.39},{"date":"2022-05-13","current":34.493385,"twenty":19.656997,"median":22.845358,"eighty":26.458476,"marketCap":238221359264.86},{"date":"2022-05-20","current":35.04583,"twenty":19.675165,"median":22.946872,"eighty":26.638996,"marketCap":245099073476.37},{"date":"2022-05-27","current":33.993818,"twenty":19.675165,"median":23.004991,"eighty":26.765296,"marketCap":241552454561.86},{"date":"2022-06-03","current":35.85784,"twenty":19.675165,"median":23.079148,"eighty":26.865014,"marketCap":254931773794.05},{"date":"2022-06-10","current":36.144957,"twenty":19.675165,"median":23.121608,"eighty":27.393726,"marketCap":252265073724.1},{"date":"2022-06-17","current":34.368146,"twenty":19.675165,"median":23.166298,"eighty":27.628683,"marketCap":238530918503.83},{"date":"2022-06-24","current":36.164256,"twenty":19.673173,"median":23.179391,"eighty":27.79533,"marketCap":253052972326.23},{"date":"2022-07-01","current":36.078675,"twenty":19.673173,"median":23.204984,"eighty":28.353802,"marketCap":248941614294.24},{"date":"2022-07-08","current":36.733396,"twenty":19.677854,"median":23.233813,"eighty":29.078428,"marketCap":248050939972.16},{"date":"2022-07-15","current":38.477295,"twenty":19.68318,"median":23.265584,"eighty":29.51183,"marketCap":257552595269.26},{"date":"2022-07-22","current":38.62089,"twenty":19.688375,"median":23.297122,"eighty":30.000399,"marketCap":261612605308.42},{"date":"2022-07-29","current":39.238181,"twenty":19.724662,"median":23.3378,"eighty":30.567554,"marketCap":265299833717.82},{"date":"2022-08-05","current":33.9049,"twenty":19.749443,"median":23.369705,"eighty":30.817686,"marketCap":233797066454.36},{"date":"2022-08-12","current":34.532769,"twenty":19.76637,"median":23.399499,"eighty":31.100772,"marketCap":240550497137.24},{"date":"2022-08-19","current":34.567929,"twenty":19.774689,"median":23.44166,"eighty":31.266201,"marketCap":235995645479.41},{"date":"2022-08-26","current":36.735139,"twenty":19.801298,"median":23.478521,"eighty":31.564711,"marketCap":249661078726.81},{"date":"2022-09-02","current":34.711366,"twenty":19.80991,"median":23.496505,"eighty":31.772799,"marketCap":236540335421.77},{"date":"2022-09-09","current":35.772175,"twenty":19.80991,"median":23.516766,"eighty":32.060199,"marketCap":243994236107.81},{"date":"2022-09-16","current":33.577882,"twenty":19.80991,"median":23.52667,"eighty":32.184846,"marketCap":228652198598.3},{"date":"2022-09-23","current":33.562399,"twenty":19.80991,"median":23.562594,"eighty":32.388066,"marketCap":221838450740.96},{"date":"2022-09-30","current":34.097523,"twenty":19.80991,"median":23.603003,"eighty":32.480977,"marketCap":227057441206.74},{"date":"2022-10-07","current":35.608351,"twenty":19.80991,"median":23.647275,"eighty":32.601214,"marketCap":236776826288.97},{"date":"2022-10-14","current":35.762264,"twenty":19.80991,"median":23.66534,"eighty":32.712656,"marketCap":236866879936.7},{"date":"2022-10-21","current":34.927501,"twenty":19.80991,"median":23.70818,"eighty":32.795741,"marketCap":232640407500.32},{"date":"2022-10-28","current":36.334718,"twenty":19.80991,"median":23.736593,"eighty":32.904554,"marketCap":245311415338.91},{"date":"2022-11-04","current":36.025251,"twenty":19.80991,"median":23.752597,"eighty":33.022881,"marketCap":253486391575.29},{"date":"2022-11-11","current":34.287547,"twenty":19.80991,"median":23.772832,"eighty":33.149296,"marketCap":251313592432.59},{"date":"2022-11-18","current":34.747541,"twenty":19.80991,"median":23.820548,"eighty":33.219794,"marketCap":255649995451.18},{"date":"2022-11-25","current":36.32397,"twenty":19.80991,"median":23.872699,"eighty":33.272915,"marketCap":268221502043.66},{"date":"2022-12-02","current":38.36767,"twenty":19.80991,"median":23.960717,"eighty":33.370587,"marketCap":285886880740.46},{"date":"2022-12-09","current":39.419984,"twenty":19.80991,"median":23.997555,"eighty":33.428897,"marketCap":295188583270.58},{"date":"2022-12-16","current":39.679987,"twenty":19.80991,"median":24.019093,"eighty":33.520896,"marketCap":298703535801.33},{"date":"2022-12-23","current":39.96019,"twenty":19.80991,"median":24.061387,"eighty":33.69655,"marketCap":301485653627.93},{"date":"2022-12-30","current":40.109853,"twenty":19.80991,"median":24.103923,"eighty":33.876977,"marketCap":304426156948.21},{"date":"2023-01-06","current":41.371304,"twenty":19.80991,"median":24.138081,"eighty":33.954949,"marketCap":311595753570.44},{"date":"2023-01-13","current":40.043335,"twenty":19.80991,"median":24.196932,"eighty":34.060145,"marketCap":307649341623.7},{"date":"2023-01-20","current":41.293188,"twenty":19.80991,"median":24.278979,"eighty":34.192763,"marketCap":317826418817.7},{"date":"2023-01-27","current":40.512746,"twenty":19.80991,"median":24.336408,"eighty":34.319787,"marketCap":312363369982.79},{"date":"2023-02-03","current":38.279951,"twenty":19.821263,"median":24.361441,"eighty":34.391915,"marketCap":309610899377.72},{"date":"2023-02-10","current":39.341875,"twenty":19.871095,"median":24.42603,"eighty":34.479595,"marketCap":313149317103.2},{"date":"2023-02-17","current":40.045228,"twenty":19.90977,"median":24.463976,"eighty":34.562541,"marketCap":318372635217.12},{"date":"2023-02-24","current":40.496042,"twenty":19.915007,"median":24.48432,"eighty":34.611678,"marketCap":318766342525.9},{"date":"2023-03-03","current":40.975861,"twenty":19.935844,"median":24.507147,"eighty":34.657591,"marketCap":324158568089.14},{"date":"2023-03-10","current":40.578164,"twenty":19.975057,"median":24.580111,"eighty":34.74851,"marketCap":322856968454.74},{"date":"2023-03-17","current":39.61958,"twenty":20.021238,"median":24.6123,"eighty":34.787619,"marketCap":315310491042.1},{"date":"2023-03-24","current":42.504639,"twenty":20.059949,"median":24.63696,"eighty":34.923103,"marketCap":340729066306.94},{"date":"2023-03-31","current":43.986878,"twenty":20.081205,"median":24.660274,"eighty":34.963352,"marketCap":356186060434.07},{"date":"2023-04-06","current":43.573665,"twenty":20.090418,"median":24.675257,"eighty":35.016273,"marketCap":354649239775.55},{"date":"2023-04-14","current":46.360726,"twenty":20.123954,"median":24.72225,"eighty":35.099792,"marketCap":381917782335.83},{"date":"2023-04-21","current":47.142452,"twenty":20.161518,"median":24.781152,"eighty":35.172139,"marketCap":385264690137.54},{"date":"2023-04-28","current":45.530972,"twenty":20.233125,"median":24.806082,"eighty":35.289466,"marketCap":373933894377.33},{"date":"2023-05-05","current":40.221678,"twenty":20.24621,"median":24.819392,"eighty":35.338524,"marketCap":363047622632.38},{"date":"2023-05-12","current":43.154329,"twenty":20.290681,"median":24.861075,"eighty":35.432998,"marketCap":386628394927.04},{"date":"2023-05-19","current":42.211241,"twenty":20.345505,"median":24.894776,"eighty":35.521575,"marketCap":373244274140.24},{"date":"2023-05-26","current":41.751553,"twenty":20.449184,"median":24.92822,"eighty":35.566491,"marketCap":367318344188.2},{"date":"2023-06-02","current":39.666966,"twenty":20.510391,"median":24.955636,"eighty":35.60151,"marketCap":349600627387.28},{"date":"2023-06-09","current":40.04981,"twenty":20.653792,"median":24.980077,"eighty":35.676661,"marketCap":354153777672.53},{"date":"2023-06-16","current":40.491233,"twenty":20.716308,"median":25.014362,"eighty":35.77087,"marketCap":362986228002.22},{"date":"2023-06-23","current":39.918598,"twenty":20.810223,"median":25.038741,"eighty":35.829434,"marketCap":358802036949.56},{"date":"2023-06-30","current":40.314089,"twenty":20.932953,"median":25.075344,"eighty":35.861925,"marketCap":360286538725},{"date":"2023-07-07","current":39.374954,"twenty":20.976299,"median":25.089284,"eighty":35.966485,"marketCap":350956082019.52},{"date":"2023-07-14","current":38.978805,"twenty":21.065152,"median":25.121898,"eighty":36.060509,"marketCap":357860491909.47},{"date":"2023-07-21","current":40.649606,"twenty":21.13475,"median":25.170404,"eighty":36.123479,"marketCap":371604321114.06},{"date":"2023-07-28","current":38.721765,"twenty":21.302742,"median":25.195792,"eighty":36.166932,"marketCap":349150330619.47},{"date":"2023-08-04","current":38.890059,"twenty":21.362374,"median":25.225531,"eighty":36.257943,"marketCap":349308076773.38},{"date":"2023-08-11","current":41.325852,"twenty":21.395991,"median":25.29959,"eighty":36.323535,"marketCap":410900879575.69},{"date":"2023-08-18","current":41.658803,"twenty":21.502217,"median":25.360565,"eighty":36.436734,"marketCap":408744326644.66},{"date":"2023-08-25","current":42.541543,"twenty":21.588834,"median":25.387131,"eighty":36.523925,"marketCap":415627881028.56},{"date":"2023-09-01","current":43.306404,"twenty":21.733119,"median":25.421229,"eighty":36.632702,"marketCap":423860503824.22},{"date":"2023-09-08","current":45.095965,"twenty":21.821469,"median":25.534657,"eighty":36.664011,"marketCap":434973298490.9},{"date":"2023-09-15","current":44.347121,"twenty":21.923559,"median":25.680125,"eighty":36.722709,"marketCap":426429019770.99},{"date":"2023-09-22","current":42.672914,"twenty":22.007754,"median":25.697302,"eighty":36.8332,"marketCap":410366712216.68},{"date":"2023-09-29","current":42.832313,"twenty":22.07509,"median":25.809613,"eighty":37.024096,"marketCap":408154856750.49},{"date":"2023-10-06","current":42.918253,"twenty":22.207177,"median":25.872228,"eighty":37.120894,"marketCap":407370553136.68},{"date":"2023-10-13","current":47.645701,"twenty":22.332343,"median":25.955394,"eighty":37.222236,"marketCap":453163623886.91},{"date":"2023-10-20","current":45.058177,"twenty":22.368839,"median":26.042141,"eighty":37.387666,"marketCap":429143426791.84},{"date":"2023-10-27","current":43.887685,"twenty":22.474887,"median":26.096293,"eighty":37.542146,"marketCap":416210847321.68},{"date":"2023-11-03","current":40.58112,"twenty":22.619194,"median":26.158954,"eighty":37.77108,"marketCap":434666614136.34},{"date":"2023-11-10","current":40.973865,"twenty":22.789886,"median":26.322084,"eighty":37.960754,"marketCap":443200545470.87},{"date":"2023-11-17","current":41.130991,"twenty":22.928807,"median":26.534941,"eighty":38.278815,"marketCap":450826686765.22},{"date":"2023-11-24","current":42.452712,"twenty":22.992251,"median":26.649888,"eighty":38.371172,"marketCap":467665323578.55},{"date":"2023-12-01","current":41.381405,"twenty":23.062639,"median":26.789389,"eighty":38.545427,"marketCap":456059104784.02},{"date":"2023-12-08","current":39.593749,"twenty":23.112425,"median":26.954141,"eighty":38.57852,"marketCap":431591715157.97},{"date":"2023-12-15","current":39.304562,"twenty":23.134475,"median":27.508344,"eighty":38.851988,"marketCap":436596264513.95},{"date":"2023-12-22","current":41.148236,"twenty":23.177477,"median":27.659038,"eighty":38.922456,"marketCap":456927579305.71},{"date":"2023-12-29","current":41.325829,"twenty":23.199394,"median":27.819753,"eighty":38.987376,"marketCap":462412313703.01},{"date":"2024-01-05","current":42.965602,"twenty":23.219176,"median":28.321673,"eighty":39.028723,"marketCap":475548268138.75},{"date":"2024-01-12","current":42.949427,"twenty":23.255339,"median":29.15552,"eighty":39.136713,"marketCap":474914873998.96},{"date":"2024-01-19","current":43.346823,"twenty":23.274802,"median":29.525036,"eighty":39.268766,"marketCap":475852126466.39},{"date":"2024-01-26","current":43.317901,"twenty":23.314329,"median":29.992393,"eighty":39.320568,"marketCap":474294338935.27},{"date":"2024-02-02","current":46.234514,"twenty":23.344449,"median":30.548898,"eighty":39.40203,"marketCap":506862514244.21},{"date":"2024-02-09","current":44.298697,"twenty":23.374655,"median":30.817262,"eighty":39.488965,"marketCap":535221795370.47},{"date":"2024-02-16","current":45.383234,"twenty":23.411773,"median":31.077019,"eighty":39.6254,"marketCap":547956628885.78},{"date":"2024-02-23","current":45.27971,"twenty":23.444798,"median":31.24152,"eighty":39.678225,"marketCap":549774093139.91},{"date":"2024-03-01","current":45.378862,"twenty":23.478521,"median":31.448374,"eighty":39.787357,"marketCap":550685531322.22},{"date":"2024-03-08","current":48.261708,"twenty":23.494902,"median":31.653026,"eighty":39.882371,"marketCap":592559559553.29},{"date":"2024-03-15","current":48.206144,"twenty":23.517781,"median":31.996876,"eighty":39.941116,"marketCap":589179395091.77},{"date":"2024-03-22","current":47.308173,"twenty":23.52667,"median":32.094328,"eighty":40.022913,"marketCap":576513565520.21},{"date":"2024-03-28","current":46.991466,"twenty":23.56157,"median":32.335943,"eighty":40.047061,"marketCap":569565272185.44},{"date":"2024-04-05","current":46.254387,"twenty":23.610109,"median":32.446311,"eighty":40.097352,"marketCap":563782608647.02},{"date":"2024-04-12","current":46.919131,"twenty":23.647275,"median":32.530991,"eighty":40.167772,"marketCap":563484763501.46},{"date":"2024-04-19","current":46.18118,"twenty":23.67588,"median":32.708949,"eighty":40.221678,"marketCap":552244543801.54},{"date":"2024-04-26","current":47.266607,"twenty":23.70686,"median":32.759891,"eighty":40.307445,"marketCap":568400976035.23},{"date":"2024-05-03","current":42.327576,"twenty":23.72852,"median":32.873681,"eighty":40.375437,"marketCap":542032137686.7},{"date":"2024-05-10","current":44.071325,"twenty":23.747994,"median":32.952292,"eighty":40.458052,"marketCap":568398548090.03},{"date":"2024-05-17","current":45.074307,"twenty":23.771696,"median":33.109472,"eighty":40.512846,"marketCap":586312155065.11},{"date":"2024-05-24","current":46.152423,"twenty":23.817376,"median":33.211469,"eighty":40.59745,"marketCap":597689451146.26},{"date":"2024-05-31","current":46.075871,"twenty":23.869365,"median":33.260802,"eighty":40.750309,"marketCap":598005342433.18},{"date":"2024-06-07","current":48.891027,"twenty":23.94497,"median":33.331764,"eighty":40.86245,"marketCap":636965793222.89},{"date":"2024-06-14","current":49.23712,"twenty":23.992049,"median":33.411951,"eighty":40.958693,"marketCap":634015536806.19},{"date":"2024-06-21","current":49.081079,"twenty":24.018117,"median":33.452653,"eighty":40.987349,"marketCap":629548189798.96},{"date":"2024-06-28","current":49.958416,"twenty":24.050958,"median":33.524546,"eighty":40.997999,"marketCap":639945526325.78},{"date":"2024-07-05","current":48.386587,"twenty":24.100535,"median":33.64639,"eighty":41.093615,"marketCap":626172096388.58},{"date":"2024-07-12","current":48.697528,"twenty":24.133679,"median":33.9049,"eighty":41.147287,"marketCap":633375419836.98},{"date":"2024-07-15","current":48.349795,"twenty":24.142207,"median":33.916253,"eighty":41.148236,"marketCap":631319457681.69},{"date":"2024-08-02","current":43.277225,"twenty":24.324844,"median":34.066375,"eighty":41.20492,"marketCap":558433557791.31},{"date":"2024-08-09","current":45.308394,"twenty":24.354431,"median":34.20007,"eighty":41.293188,"marketCap":595404735213.97},{"date":"2024-08-16","current":45.327027,"twenty":24.378479,"median":34.369684,"eighty":41.371304,"marketCap":599974249962.6},{"date":"2024-08-23","current":44.979837,"twenty":24.435013,"median":34.405605,"eighty":41.504975,"marketCap":602123632142.67},{"date":"2024-08-30","current":46.26495,"twenty":24.468615,"median":34.493385,"eighty":41.651415,"marketCap":617587789526.57},{"date":"2024-09-06","current":43.473567,"twenty":24.503203,"median":34.563439,"eighty":41.809219,"marketCap":580445608156.15},{"date":"2024-09-13","current":45.294072,"twenty":24.553916,"median":34.628664,"eighty":41.991754,"marketCap":602074290582.18},{"date":"2024-09-20","current":41.914122,"twenty":24.601207,"median":34.6594,"eighty":42.133495,"marketCap":562891500149.39},{"date":"2024-09-27","current":39.27396,"twenty":24.620356,"median":34.750892,"eighty":42.133495,"marketCap":529136949972.05},{"date":"2024-10-04","current":38.369837,"twenty":24.655215,"median":34.800683,"eighty":42.133495,"marketCap":509214271221.05},{"date":"2024-10-11","current":40.453418,"twenty":24.672651,"median":34.934073,"eighty":42.133495,"marketCap":532616097425.88},{"date":"2024-10-18","current":39.795556,"twenty":24.712429,"median":34.993514,"eighty":42.133495,"marketCap":519765515915.47},{"date":"2024-10-25","current":38.664562,"twenty":24.763881,"median":35.053901,"eighty":42.133495,"marketCap":503297302214.39},{"date":"2024-10-31","current":37.617459,"twenty":24.792436,"median":35.126549,"eighty":42.133495,"marketCap":492283882920.54},{"date":"2024-11-08","current":34.887986,"twenty":24.818477,"median":35.164897,"eighty":42.137734,"marketCap":477919893645.19},{"date":"2024-11-15","current":33.262315,"twenty":24.856702,"median":35.192364,"eighty":42.137734,"marketCap":446793417547.9},{"date":"2024-11-22","current":35.223595,"twenty":24.88501,"median":35.223595,"eighty":42.137734,"marketCap":469179356606.58},{"date":"2024-11-29","current":35.372703,"twenty":24.919825,"median":35.281864,"eighty":42.137734,"marketCap":473954081305.87},{"date":"2024-12-06","current":36.689896,"twenty":24.953215,"median":35.332303,"eighty":42.137734,"marketCap":492636422090.58},{"date":"2024-12-13","current":35.218563,"twenty":24.976183,"median":35.367525,"eighty":42.137734,"marketCap":469483368412.58},{"date":"2024-12-20","current":27.520925,"twenty":25.013317,"median":35.430794,"eighty":42.137734,"marketCap":362794059840.34},{"date":"2024-12-27","current":29.702234,"twenty":25.030076,"median":35.430794,"eighty":42.137734,"marketCap":392886562515.1},{"date":"2025-01-03","current":29.891519,"twenty":25.058285,"median":35.430794,"eighty":42.137734,"marketCap":389201398303.45},{"date":"2025-01-10","current":29.647698,"twenty":25.082233,"median":35.432631,"eighty":42.141973,"marketCap":387516656006.71},{"date":"2025-01-17","current":26.984988,"twenty":25.10605,"median":35.432631,"eighty":42.141973,"marketCap":352861160824.4},{"date":"2025-01-24","current":29.17577,"twenty":25.124624,"median":35.432631,"eighty":42.141973,"marketCap":385565237898.86},{"date":"2025-01-31","current":28.464542,"twenty":25.161796,"median":35.432631,"eighty":42.141973,"marketCap":376696466562.58},{"date":"2025-02-07","current":27.64408,"twenty":25.17357,"median":35.432631,"eighty":42.141973,"marketCap":388211259356.66},{"date":"2025-02-14","current":24.505604,"twenty":25.161796,"median":35.432631,"eighty":42.141973,"marketCap":346492190720.85},{"date":"2025-02-21","current":27.692432,"twenty":25.161796,"median":35.432631,"eighty":42.141973,"marketCap":392454499955.8},{"date":"2025-02-28","current":28.329797,"twenty":25.170588,"median":35.432631,"eighty":42.141973,"marketCap":399184817306.47},{"date":"2025-03-07","current":26.26825,"twenty":25.192741,"median":35.434467,"eighty":42.146211,"marketCap":385230479837.53},{"date":"2025-03-14","current":23.305599,"twenty":25.192741,"median":35.434467,"eighty":42.146211,"marketCap":342708135805.47},{"date":"2025-03-21","current":23.24406,"twenty":25.192741,"median":35.434467,"eighty":42.146211,"marketCap":341394090983.94},{"date":"2025-03-28","current":20.837456,"twenty":25.192741,"median":35.434467,"eighty":42.146211,"marketCap":304502715067.03},{"date":"2025-04-04","current":18.989096,"twenty":25.192741,"median":35.434467,"eighty":42.146211,"marketCap":284263623540.71},{"date":"2025-04-11","current":18.474808,"twenty":25.184615,"median":35.432631,"eighty":42.141973,"marketCap":279691712454.2},{"date":"2025-04-17","current":18.516566,"twenty":25.17357,"median":35.432631,"eighty":42.141973,"marketCap":284856366575.72}],"updateTime":1745308247146}}}